Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Ashley Tewksbury"'
Autor:
Kristin Waters, Ashley Tewksbury
Publikováno v:
Journal of the American Pharmacists Association : JAPhA. 62(5)
The objective of this case report is to highlight the possibility of the second-generation antipsychotic ziprasidone causing a false positive result for fentanyl on a urine drug screen (UDS).A 70-year-old female was admitted to an inpatient psychiatr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dead5b484c317f923293d8befc6e2548
https://pubmed.ncbi.nlm.nih.gov/35672206
https://pubmed.ncbi.nlm.nih.gov/35672206
Publikováno v:
The Mental Health Clinician
Introduction: Valproic acid (VPA)–induced hyperammonemia poses several clinical challenges in psychiatric medicine. The reported incidence of this adverse effect varies widely across the literature. Furthermore, practitioners treat hyperammonemia i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::741eea66875974701834d33490289853
https://pubmed.ncbi.nlm.nih.gov/29955549
https://pubmed.ncbi.nlm.nih.gov/29955549
Autor:
Elizabeth Ann Cunningham, Laura Ruekert, Kevin M Bozymski, Ashley Tewksbury, Frank Covington, Cheen Lum
Publikováno v:
Journal of pharmacy practice. 31(3)
Collaborative drug therapy management (CDTM) is a written agreement that allows a pharmacist to initiate, modify, or continue pharmacotherapies under a physician’s scope of practice. While available literature pertaining to cardiometabolic and resp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1631bc63a6e3fb24f0204057ac3f51d2
https://pubmed.ncbi.nlm.nih.gov/28539104
https://pubmed.ncbi.nlm.nih.gov/28539104
Autor:
Ashley Tewksbury, Jessica L. Gören
Publikováno v:
Polypharmacy in Psychiatry Practice, Volume I ISBN: 9789400758049
Over the past 20 years the number of psychotropic medications has increased dramatically. As a result, the use of psychotropic polypharmacy has rapidly expanded. One outcome of psychotropic polypharmacy has been an increase in the number of drug inte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9bea29930c02763dd1d612d6f9fad494
https://doi.org/10.1007/978-94-007-5805-6_3
https://doi.org/10.1007/978-94-007-5805-6_3
Publikováno v:
Journal of Pharmacy Practice; Oct2018, Vol. 31 Issue 5, p525-593, 69p
Autor:
Tewksbury, Ashley, Bozymski, Kevin M., Ruekert, Laura, Lum, Cheen, Cunningham, Elizabeth, Covington, Frank
Publikováno v:
Journal of Pharmacy Practice; Jun2018, Vol. 31 Issue 3, p272-278, 7p
Publikováno v:
Journal of Pharmacy Practice; Aug2017, Vol. 30 Issue 4, pNP17-NP90, 74p
Autor:
Michael S Ritsner
Although monotherapy is generally recommended as the treatment of choice, treatment resistance of patients with psychosis, cognitive, mood and anxiety disorders represents a significant clinical problem. In this context, augmentation and combination
Autor:
Michael S Ritsner
Although monotherapy is generally recommended as the treatment of choice, treatment resistance of patients with psychosis, cognitive, mood and anxiety disorders represents a significant clinical problem. In this context, augmentation and combination